Frequently Asked Questions
China is expected to witness the highest CAGR in the risk-based monitoring software market. The rapid expansion of the healthcare and pharmaceutical industries in China, along with increasing investments in clinical trials and technological advancements, is driving the demand for RBM solutions.
The growing emphasis on growing integration of artificial intelligence and machine learning algorithms into these software solutions, is emerging as a pivotal trend driving the global risk-based monitoring software market.
